Shalby Ltd Stock Price Today (NSE: SHALBY)
Fundamental Score
Shalby Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Shalby Ltd share price today is ₹156.49, up +0.00% on NSE/BSE as of 20 February 2026. Shalby Ltd (SHALBY) is a Small-cap company in the Hospital sector with a market capitalisation of ₹2.24K (Cr). The 52-week high for SHALBY share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 500.81x, SHALBY is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 0.62% and a debt-to-equity ratio of 0.53.
Shalby Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Shalby Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Shalby Share Price: A Financial Analysis for Growth Potential
The "Shalby share price" currently stands at ₹173.990005. Understanding the factors influencing its movement requires a deep dive into its financials and competitive landscape. One crucial observation about the hospital industry is its increasing consolidation, with larger players like Shalby attempting to expand their reach and services. This trend necessitates scrutinizing a company's ability to generate returns efficiently.
Shalby Ltd's current Price-to-Earnings (PE) ratio of 500.81 is significantly higher than the sector average, suggesting the market has high expectations for future earnings growth. However, the Return on Capital Employed (ROCE) of 6.12% raises questions. ROCE measures how effectively a company uses its capital to generate profits. A lower ROCE, like Shalby's, indicates that the company may not be as efficient at deploying capital as its competitors. This relatively low ROCE directly impacts the strength of Shalby’s economic moat – its ability to protect its market share and profitability. A more robust ROCE would signal a stronger competitive advantage.
Comparing Shalby with peers provides crucial context. Consider
Nephro Care India Limited. While financial data is essential, subjective elements like management quality play a significant role. Assessing the historical performance of the management team at Nephro Care India Limited, their strategic decisions, and capital allocation efficiency provides a valuable benchmark when evaluating Shalby's management and potential for future growth. A similar analysis of Strategic Minerals Plc and Abateas Industries Ltd would also be beneficial.In conclusion, the current "Shalby share price" reflects a potential premium embedded in the stock, likely driven by growth expectations. However, the relatively low ROCE necessitates careful consideration. Further investigation into the company's cost structure, revenue generation strategies, and competitive positioning within the consolidating hospital market is crucial. This analysis forms part of an 80-parameter fundamental audit verified by Sweta Mishra, aimed at providing a comprehensive view of Shalby Ltd's financial health and growth prospects. This analysis is purely observational and does not constitute investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Shalby Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SHALBY across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Operating Margins (16.74%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (147.49%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (17.43% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Balanced Promoter Holding (74.33%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (0.62%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.12%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 500.81x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Weak Earnings Growth (-25.71% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-25.71% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Weak Interest Coverage (2.32x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-21.02 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 4.82%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Shalby Ltd Financial Statements
Comprehensive financial data for Shalby Ltd including income statement, balance sheet and cash flow
About SHALBY (Shalby Ltd)
Shalby Ltd (SHALBY) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current market capitalisation of ₹2.24K (Cr). Shalby Ltd has delivered a Return on Equity (ROE) of 0.62% and a ROCE of 6.12%. The debt-to-equity ratio stands at 0.53, reflecting the company's capital structure. Investors tracking SHALBY share price can monitor key metrics including P/E ratio, promoter holding of 74.33%, and quarterly earnings growth.
Company Details
Key Leadership
SHALBY Share Price: Frequently Asked Questions
What is the current share price of Shalby Ltd (SHALBY)?
As of 20 Feb 2026, 06:24 am IST, Shalby Ltd share price is ₹156.49. The SHALBY stock has a market capitalisation of ₹2.24K (Cr) on NSE/BSE.
Is SHALBY share price Overvalued or Undervalued?
SHALBY share price is currently trading at a P/E ratio of 500.81x, compared to the industry average of 52.84x. Based on this relative valuation, the Shalby Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of SHALBY share price?
The 52-week high of SHALBY share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Shalby Ltd share price?
Key factors influencing SHALBY share price include quarterly earnings growth (Sales Growth: 6.69%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Shalby Ltd a good stock for long-term investment?
Shalby Ltd shows a 5-year Profit Growth of -25.71% and an ROE of 0.62%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.53 before investing in SHALBY shares.
How does Shalby Ltd compare with its industry peers?
Shalby Ltd competes with major peers in the Hospital. Investors should compare SHALBY share price P/E of 500.81x and ROE of 0.62% against the industry averages to determine competitive standing.
What is the P/E ratio of SHALBY and what does it mean?
SHALBY share price has a P/E ratio of 500.81x compared to the industry average of 52.84x. Investors pay ₹501 for every ₹1 of annual earnings.
How is SHALBY performing according to Bull Run's analysis?
SHALBY has a Bull Run fundamental score of 30.7/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does SHALBY belong to?
SHALBY operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Shalby Ltd share price.
What is Return on Equity (ROE) and why is it important for SHALBY?
SHALBY has an ROE of 0.62%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Shalby Ltd generates profits from shareholders capital.
How is SHALBY debt-to-equity ratio and what does it indicate?
SHALBY has a debt-to-equity ratio of 0.53, which indicates moderate leverage that should be monitored.
What is SHALBY dividend yield and is it a good dividend stock?
SHALBY offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Shalby Ltd shares.
How has SHALBY share price grown over the past 5 years?
SHALBY has achieved 5-year growth rates of: Sales Growth 17.43%, Profit Growth -25.71%, and EPS Growth -25.71%.
What is the promoter holding in SHALBY and why does it matter?
Promoters hold 74.33% of SHALBY shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Shalby Ltd.
What is SHALBY market capitalisation category?
SHALBY has a market capitalisation of ₹2244 crores, placing it in the Small-cap category.
How volatile is SHALBY stock?
SHALBY has a beta of N/A. A beta > 1 suggests the Shalby Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is SHALBY operating profit margin trend?
SHALBY has a 5-year average Operating Profit Margin (OPM) of 16.74%, indicating the company's operational efficiency.
How is SHALBY quarterly performance?
Recent quarterly performance shows Shalby Ltd YoY Sales Growth of 6.69% and YoY Profit Growth of 147.49%.
What is the institutional holding pattern in SHALBY?
SHALBY has FII holding of 4.63% and DII holding of 0.19%. Significant institutional holding often suggests professional confidence in the Shalby Ltd stock.